Trending Topics in Gastroenterology
Explore current gastroenterology questions, clinical answers, and emerging research by topic.
Explore current gastroenterology questions, clinical answers, and emerging research by topic.
What Did the Review Find? Metabolic and alcohol-associated liver disease (MetALD) describes steatotic liver disease with at least one cardiometabolic risk factor and alcohol intake in the intermediate...
What Did the Study Find? CORTISAVE addressed a specific bedside dilemma: whether to start corticosteroids in biopsy-confirmed severe alcohol-related hepatitis when bilirubin has already fallen by more than...
What Did the Study Find? Investigators prospectively studied 607 adults with overweight or obesity, 55% of whom were women; mean age was 51.2 years and mean BMI 32.6...
What Did the Study Find? The AGA defines MetALD as steatotic liver disease with cardiometabolic risk plus alcohol exposure of approximately 140–350 g/week in women or 210–420 g/week...
What Did the Study Find? The updated WGO guideline provides a resource-sensitive framework spanning HBV prevention, testing, treatment, monitoring and linkage to care. Rather than requiring every setting...
What Did the Study Find? The Indian RESOLVE trial randomised 880 treatment-naive adults with chronic HCV infection without cirrhosis to sofosbuvir 400 mg/velpatasvir 100 mg once daily for...
What Did the Study Find? This analysis included 778 patients with alcohol-associated hepatitis (AH) from the US multicenter AlcHepNet observational cohort and randomized trial; 39.8% had obesity. Pasted...
What Does the AGA Recommend? The new AGA Clinical Practice Update provides 9 Best Practice Advice statements for MetALD—the increasingly recognised overlap between metabolic dysfunction and clinically relevant...
What Did the Study Find? This pilot RCT evaluated pre-emptive CRRT in patients with acute liver failure (ALF) and cerebral edema receiving therapeutic plasma exchange. Starting CRRT within...
What Did the Study Find? This two-center cohort followed 1,010 patients with chronic hepatitis B, with 129 developing hepatocellular carcinoma (HCC) during 3,684 person-years of follow-up. HCC risk...
We are pioneers in clinical intelligence, dedicated to helping gastroenterologists harness the power of artificial intelligence to drive precision, efficiency, and patient growth.